PTN
Palatin Technologies Inc
AMEX: PTN · HEALTHCARE · BIOTECHNOLOGY
$20.21
-0.30% today
Updated 2026-04-30
Market cap
$37.58M
P/E ratio
—
P/S ratio
4.19x
EPS (TTM)
$-8.26
Dividend yield
—
52W range
$2 – $31
Volume
0.0M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+2.0
Profitability
F5.7
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$54.33
+168.83%
12-Month target
—
—
Intrinsic (DCF)
$21.70
Margin of safety
+24.01%
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 24.01% below intrinsic value
Risks
- Thin margins at -107.40%
- Negative free cash flow $-4.82M
- Revenue declining -80.10% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.47M | $4.85M | $4.49M | $0.00 | $8.96M |
| Net income | $-35.81M | $-27.54M | $-29.74M | $-17.31M | $-7.26M |
| EPS | — | — | — | — | $-8.26 |
| Free cash flow | $-30.18M | $-28.85M | $-31.50M | $-21.31M | $-4.82M |
| Profit margin | -2,438.49% | -567.44% | -662.26% | — | -107.40% |
Peer comparison
Smart narrative
Palatin Technologies Inc trades at $20.21. Our Smart Value Score of 26/100 indicates the stock is weak. TTM revenue stands at $8.96M. with profit margins at -107.40%. Our DCF model estimates intrinsic value at $21.70.
Frequently asked questions
What is Palatin Technologies Inc's stock price?
Palatin Technologies Inc (PTN) trades at $20.21.
Is Palatin Technologies Inc overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell). DCF value $21.70.
What is the price target of Palatin Technologies Inc (PTN)?
The analyst target price is $54.33, representing +168.8% upside from the current price of $20.21.
What is the intrinsic value of Palatin Technologies Inc (PTN)?
Based on our DCF model, intrinsic value is $21.70, a +24.0% margin of safety versus $20.21.
What is Palatin Technologies Inc's revenue?
TTM revenue is $8.96M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeAMEX
CurrencyUSD
Quick metrics
P/S ratio4.19x
ROE-378.70%
Beta-0.15
50D MA$20.87
200D MA$14.49
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—